New England Cell Therapeutics, Inc.

This study tested whether a treatment made from a patient's own bone marrow stem cells (called STR04) could help control Amyotrophic Lateral Sclerosis (ALS). The goal was to see if four intravenous doses could slow the decline in muscle function and breathing. The trial was termi…